Priority Research Papers:
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
Metrics: PDF 6389 views | HTML 7132 views | ?
Abstract
Chuanzhao Zhang1,2, Wanqing Iris Zhi3, Haiquan Lu1,9, Debangshu Samanta1,9, Ivan Chen1,9, Edward Gabrielson3,4 and Gregg L. Semenza1,3,5,6,7,8,9
1 Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD, USA
2 Department of General Surgery, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
3 Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
4 Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
5 Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA
6 Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
7 Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
8 Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD, USA
9 McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Correspondence to:
Gregg L. Semenza, email:
Keywords: breast cancer stem cells; hypoxia; metastasis; N6-methyladenosine; pluripotency factors
Received: August 02, 2016 Accepted: August 12, 2016 Published: August 31, 2016
Abstract
Exposure of breast cancer cells to hypoxia increases the percentage of breast cancer stem cells (BCSCs), which are required for tumor initiation and metastasis, and this response is dependent on the activity of hypoxia-inducible factors (HIFs). We previously reported that exposure of breast cancer cells to hypoxia induces the ALKBH5-mediated demethylation of N6-methyladenosine (m6A) in NANOG mRNA leading to increased expression of NANOG, which is a pluripotency factor that promotes BCSC specification. Here we report that exposure of breast cancer cells to hypoxia also induces ZNF217-dependent inhibition of m6A methylation of mRNAs encoding NANOG and KLF4, which is another pluripotency factor that mediates BCSC specification. Although hypoxia induced the BCSC phenotype in all breast-cancer cell lines analyzed, it did so through variable induction of pluripotency factors and ALKBH5 or ZNF217. However, in every breast cancer line, the hypoxic induction of pluripotency factor and ALKBH5 or ZNF217 expression was HIF-dependent. Immunohistochemistry revealed that expression of HIF-1α and ALKBH5 was concordant in all human breast cancer biopsies analyzed. ALKBH5 knockdown in MDA-MB-231 breast cancer cells significantly decreased metastasis from breast to lungs in immunodeficient mice. Thus, HIFs stimulate pluripotency factor expression and BCSC specification by negative regulation of RNA methylation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11743